Cepharanthine – Usoro mmịpụta patent

Dị ka ọgwụ nwere ike igbochi COVID_19,cepharanthinebụ isi ihe na-arụsi ọrụ ike nke ewepụtara na Stephania, ọgwụ ọdịnala ndị China. Edepụtala ọgwụ patent China na China na mba ofesi ihe karịrị afọ 40.
Cepharanthine1
Na Mee 10,2022, ndị ọkà mmụta sayensị China achọpụtala ọgwụgwọ maka covid_19 ọgwụ ọhụrụ enwetara ikike ikike nke mba mepụtara. Nkọwa patent na-egosi na 10μM (micromol/L) cepharanthine na-egbochi mmegharị coronavirus site na 15393 ugboro.

Ozugbo ozi a pụtara, ọ bụ ihe na-akpali akpali tupu edozi COVID 19 nke ọma. Ọ bụ ezie na cepharanthine ka nọ na nyocha ọgwụ na mmepe mmepe ma etinyebeghị ya n'ụzọ iwu na omume ụlọ ọgwụ, ọ bụkwa ozi ọma maka ọnọdụ achọghị nke ugbu a nke Covid 19. Ọzọkwa, dị ka akụkọ mgbasa ozi si kwuo, ụfọdụ ndị ọkà mmụta America ebipụtalarị akwụkwọ na sayensị ma kwenye na data nyocha nke cepharanthine dị mma karịa paxlovid, nke akwadoro maka ịdepụta. Ugbu a, onye Canada Ụlọ ọrụ na-emepụta ọgwụ akpọtụrụla US FDA ka ha mee nyocha ụlọ ọgwụ gbasara ọgwụgwọ COVID-19 na Cepharanthine. A na-atụ anya na a ga-enwe ọganihu ka mma na R&D na iji ọgwụ a eme ihe n'ọdịnihu dị nso.
Cepharanthine (CEP) bụ alkaloid sitere n'okike nke sitere na Stephania cepharantha Hayata wee gosipụta na ọ nwere ihe mgbochi mkpali pụrụ iche, antioxidative, immunomodulating, antiparasitic na antiviral Njirimara.

Ike ọgwụgwọ ya dị ka onye na-ahụ maka nje anaghị adị mkpa karịa ịlụso COVID-19 ọgụ nke ọrịa coronavirus ụdị 2 (SARS-CoV-2) kpatara.

N'ime ole na ole patent nwe, anyị nwere patent metụtaraCepharanthine.
Cepharanthine02

Cepharanthine03

Yunnan Hande Bio-tech Co., Ltd bụ a emeputa na soplaya na 28+ ahụmahụ na elu ịta mmịpụta na nkewa nke osisi.We patented na mmịpụta usoro.Cepharanthinedị ka n'oge dị ka August 2011.Our patent na-akọwa n'ụzọ zuru ezu otú e si amịpụta stephanine. Ọ bụrụ na ị chọrọ Cepharanthine na nke a, egbula oge, biko kpọtụrụ anyị ozugbo.


Oge nzipu: Mee-16-2022